Clinicopathologic Conference, Mycobacterium Tuberculosis Meningitis
NEJM 384:166-176, Case 1-2021, 2021
Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019
Clinicopathologic Conference, Digitalis Toxicity
NEJM 378:1931-1938, Case 15-2018, 2018
Clinicopathologic Conference, Pulmonary Adenocarcinoma, Complicated by a Hypercoagulable State with a Nonbacterial Thrombotic Endocarditis
NEJM, Case 33-2018, 2018
Clinical Outcomes after Neurogenic Stress Induced Cardiomyopathy in Aneurysmal Sub-Arachnoid Hemorrhage: A Prospective Cohort Study
Clin Neurol Neurosurg 128:4-9, Kilbourn, K.J.,et al, 2015
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
NEJM 381:142-149, Lipton, R.B.,et al, 2019
Trial of Galcanezumab in Prevention of Episodic Cluster Headache
NEJM 381:132-141, Goadsby, P.J.,et al, 2019
Preventive Migraine Drug Approved
JAMA 320:1746, , 2018
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018
Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018
CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017
New Drugs in Migraine Treatment and Prophylaxis: Telcagepant and Topiramate
Lancet 376:645-655, Edvinsson,L. &Linde,M., 2010
Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996
Serum Cortisol and Cerebrospinal Fluid B-Endorphins in Status Epilepticus:Their Possible Relation to Prognosis
Arch Neurol 50:689-693, Calabrese,V.P.,et al, 1993
Effect of Calcitonin-Gene-Related Peptide in Pts with Delayed Postop Cerebral Ischaemia after Aneurysmal SAH
Europ CGRP Study Group, Lancet 339:831-8341992., , 1992
Effect of Calcitonin-Gene-Related Peptide on Postoperative Neurological Deficits after Subarachnoid Haemorrhage
Lancet 335:869-872, Johnston,F.G.,et al, 1990
Vasoactive Peptide Release in the Extracerebral Circulation of Humans During Migraine Headache
Ann Neurol 28:183-187, Goadsby,P.J.,et al, 1990
Huntington's Disease, Pathogenesis & Management
NEJM 315:1267-1276, Martin,J.B.&Gusella,J.F., 1986
Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986
Effects of Naloxone in Senile Dementia:A Double-Blind Trial
NEJM 308:721-722, Reisberg,B.,et al, 1983
Acupuncture Relief of Chronic Pain Syndrome Correlates with Increased Plasma Met-Enkephalin Concentra
Lancet 2:1394-1396, Kiser,R.S.,et al, 1983
Neurotransmitters & CNS Disease
Lancet 2:914-918, Iversen,L.L., 1982
Cerebrospinal Fluid:A Selective Review
Ann Neurol 11; 1-101982., Cutler,R.W.P.,et al, 1982
How Does Acupuncture Work? Editorial
BMJ 283:746-748, , 1981
Thyrotropin-Releasing Hormone Improves Neurologic Recovery After Spinal Trauma In Cats
NEJM 305:1063-1067, Faden,A.I.,et al, 1981
Acupuncture Treatments for Pain Relief
JAMA 245:768-769, Ulett,G.A., 1981
Pain II:New Approaches to Management
Ann Neurol 9:101-106, Fields,H.L., 1981
Brain Peptides
(part I & II) NEJM 304:876-885, 944-951., Krieger,D.T.&Martin,J.G., 1981
Neuroendocrinology & Brain Peptides
Ann Neurol 8:551-557, Cooper,P.E.,et al, 1980
Opiate Peptides
Analgesia, & the Neuroendocrine System, Editorial, BMJ 1:741-742., , 1980
Hyper-Endorphin Syndrome in a Child With Necrotizing Encephalomyelopathy
NEJM 303:914-916, Brandt,N.J.,et al, 1980
Cortical Evoked Responses & Transcutaneous Electrotherapy
Neurol 30:663-665, Salar,G.,et al, 1980
Pain Sensitivity In Schizophrenics
NEJM 301:946-947, Hoo,J.J.,et al, 1979
Opiate Receptors in the Brain
NEJM 296:266, Snyder,S.H., 1977